158 related articles for article (PubMed ID: 25927275)
21. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Classen V; Bernges U; Philipp M
Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
[TBL] [Abstract][Full Text] [Related]
22. No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
Li C; Xiang X; Zhou Y
Mol Biol Rep; 2014 Nov; 41(11):7613-21. PubMed ID: 25086624
[TBL] [Abstract][Full Text] [Related]
23. XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis.
Wang B; Wang D; Huang G; Zhang C; Xu DH; Zhou W
Int J Colorectal Dis; 2010 Mar; 25(3):313-21. PubMed ID: 20033188
[TBL] [Abstract][Full Text] [Related]
24. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
Saadat M; Ansari-Lari M
Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
[TBL] [Abstract][Full Text] [Related]
25. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies.
Wu K; Su D; Lin K; Luo J; Au WW
Asian Pac J Cancer Prev; 2011; 12(9):2237-43. PubMed ID: 22296363
[TBL] [Abstract][Full Text] [Related]
26. Lack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis.
Liu BM; Liu TM; You BS; You HY; Yang J; Li L; He YC
Genet Mol Res; 2012 Nov; 11(4):3852-60. PubMed ID: 23212324
[TBL] [Abstract][Full Text] [Related]
27. XRCC1 Arg399Gln polymorphism and bladder cancer risk: updated meta-analyses based on 5767 cases and 6919 controls.
Zhuo W; Zhang L; Cai L; Zhu B; Chen Z
Exp Biol Med (Maywood); 2013 Jan; 238(1):66-76. PubMed ID: 23479765
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in DNA repair gene XRCC1 and skin cancer risk: a meta-analysis.
Zhang H; Li W; Franklin MJ; Dudek AZ
Anticancer Res; 2011 Nov; 31(11):3945-52. PubMed ID: 22110224
[TBL] [Abstract][Full Text] [Related]
29. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis.
Xue H; Ni P; Lin B; Xu H; Huang G
Am J Epidemiol; 2011 Feb; 173(4):363-75. PubMed ID: 21216841
[TBL] [Abstract][Full Text] [Related]
30. XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a meta-analysis.
Geng J; Zhang Q; Zhu C; Wang J; Chen L
Urology; 2009 Sep; 74(3):648-53. PubMed ID: 19428062
[TBL] [Abstract][Full Text] [Related]
31. Association between polymorphisms in the XRCC1 gene and the risk of non-small cell lung cancer.
Han JC; Zhang YJ; Li XD
Genet Mol Res; 2015 Oct; 14(4):12888-93. PubMed ID: 26505441
[TBL] [Abstract][Full Text] [Related]
32. Quantitative assessment of the associations between XRCC1 polymorphisms and bladder cancer risk.
Mao Y; Xu X; Lin Y; Chen H; Wu J; Hu Z; Zhu Y; Xu X; Xie L
World J Surg Oncol; 2013 Mar; 11():58. PubMed ID: 23496911
[TBL] [Abstract][Full Text] [Related]
33. Association and Intragenic Single-Nucleotide Polymorphism Interactions of the XRCC1 Polymorphisms for Pancreatic Cancer Susceptibility.
Hou BH; Jian ZX; Cui P; Li SJ; Tian RQ; Ou JR
Pancreas; 2016 Apr; 45(4):546-51. PubMed ID: 26418909
[TBL] [Abstract][Full Text] [Related]
34. Lack of association between leptin G-2548A polymorphisms and obesity risk: Evidence based on a meta-analysis.
Yan J; Wang X; Tao H; Yang W; Luo M; Lin F
Obes Res Clin Pract; 2015; 9(4):389-97. PubMed ID: 25733497
[TBL] [Abstract][Full Text] [Related]
35. The association between the Arg280His polymorphism in the XRCC1 gene and the risk of hematological malignancies.
Tong X; Yang J; Peng Y; Shen J; Xiong T; Zhang Y; Fan H
Tumour Biol; 2014 Feb; 35(2):1687-93. PubMed ID: 24096581
[TBL] [Abstract][Full Text] [Related]
36. Role of GSTP1 Ile105Val and XRCC1 Arg194Trp, Arg280His and Arg399Gln gene polymorphisms in the clinical outcome of advanced non-small cell lung cancer.
Zhao R; Chen G
Int J Clin Exp Pathol; 2015; 8(11):14909-16. PubMed ID: 26823821
[TBL] [Abstract][Full Text] [Related]
37. Association between XRCC1 Arg280His polymorphism and risk of hepatocellular carcinoma: a systematic review and meta-analysis.
Xu W; Liu SA; Li L; Shen ZY; Wu YL
Genet Mol Res; 2015 Jun; 14(2):7122-9. PubMed ID: 26125922
[TBL] [Abstract][Full Text] [Related]
38. A meta-analysis of an association between the XRCC1 polymorphisms and gliomas risk.
Li M; Zhou Q; Tu C; Jiang Y
J Neurooncol; 2013 Feb; 111(3):221-8. PubMed ID: 23238971
[TBL] [Abstract][Full Text] [Related]
39. X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism significantly associated with prostate cancer.
Chen Y; Li T; Li J; Mo Z
Int J Biol Markers; 2015 Feb; 30(1):e12-21. PubMed ID: 25262700
[TBL] [Abstract][Full Text] [Related]
40. XRCC1 Arg399Gln polymorphism confers risk of breast cancer in American population: a meta-analysis of 10846 cases and 11723 controls.
Bu T; Liu L; Sun Y; Zhao L; Peng Y; Zhou S; Li L; Chen S; Gao Y
PLoS One; 2014; 9(1):e86086. PubMed ID: 24489692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
